AstraZeneca in $560 m deal for respiratory firm
British drugmaker AstraZeneca PLC says it is to acquire Pearl Therapeutics Inc., a Redwood-City, California-based company involved in therapies for asthma and chronic obstructive pulmonary disease for at least $560 million.
Join the discussion below, or Read more at Seattle Times.
Since: Apr 13
#1 Jun 10, 2013
This sounds promising.
Add your comments below
|Groups offer summer lunches: Programs hope to f... (Jun '14)||Feb 20||Ricardo||3|
|Tesla stands to reap solar-tariff rewards as ri...||Feb 19||Solarman||1|
|specialized bicycle company Problem||Feb 10||JammedTrailBike||1|
|Help finding old acquaintance?||Feb 9||Peter le Cornu||1|
|Word Game (Aug '14)||Feb 7||winner||2|
|Man gets 6 months in cockfighting (Mar '08)||Feb 4||un agenda 21||25|
|My Teen Verbally Abuses Me (Feb '09)||Feb 1||CDNClerk||143|
Find what you want!
Search Redwood City Forum Now
Copyright © 2018 Topix LLC